Dreamm-7: A Phase Iii Study Of The Efficacy And Safety Of Belantamab Mafodotin With Bortezomib And Dexamethasone In Patients With Relapsed/Refractory Multiple MyelomaRobert Rifkin,Kevin Boyd,Sebastian Grosicki,Kihyun Kim,Francesco Di Raimondo,Meletios Dimopoulos,Katja Weisel,Bertrand Arnulf,Roman Hajek,Vania Hungria,Andrew Spencer,Randy Davis,Antonio Riccio,Chanbin Kim,Jodie Wilkes,Ruth Rutledge,Mala Talekar,Brandon E. Kremer,Ira Gupta,Maria Victoria Mateos MantecaBRITISH JOURNAL OF HAEMATOLOGY（2021）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
